Skip to main content
Covid and vaccinationVitiligo Scientific Study

COVID‐19 and autoimmune phenomena: Vitiligo after Astrazeneca vaccine

By 13 September 2022October 16th, 2023No Comments

by Irene López Riquelme,corresponding author 1 María Dolores Fernández Ballesteros, 1 Ana Serrano Ordoñez, 1 and Daniel Jesús Godoy Díaz

Aktas et al. published an interesting case of vitiligo after COVID‐19 vaccination.Recently, similar cases of vitiligo have been reported after,as well as other cutaneous reactions after COVID‐19 vaccination (both mRNA and ChAdOx1 vaccines) such as immune thrombocytopenic purpura and psoriatic flare‐up.Even though no cutaneous adverse events were encountered in Phase 3 studies of mRNA vaccines, the chronology of the symptoms is very suggestive. We would like to report another case of vitiligo 3 days after COVID‐19 vaccine and to comment about possible theories that have been suggested to explain autoimmune phenomena and vitiligo following COVID 19 infection or vaccination.

A 60 year‐old woman presented to the Dermatology department with amelanotic macules and patches in her face and arms that have appeared in the last 3 weeks. Three days before the onset of the symptoms, she had received the first dose of Astrazeneca vaccine against COVID‐19 (ChAdOx1/AZD1222).

On physical examination, circumscribed depigmented patches were observed, affecting both cheeks (Figure 1), forehead and between the eyebrows, as well as both arms. The lesions became more clearly visible when examined under Wood’s lamp (Figure 2).

An external file that holds a picture, illustration, etc. Object name is DTH-35-0-g002.jpg

Well‐circumscribed depigmented patches in both cheeks, forehead and between eyebrows

An external file that holds a picture, illustration, etc. Object name is DTH-35-0-g001.jpg

Depigmented patches were more noticeable when examined under Wood’s lamp

Blood test including thyrotropin was normal. Antithyroid peroxidase and antithyroglobulin antibodies were negative. With the diagnosis of vitiligo, she initiated a treatment with tacrolimus ointment 0.1% twice a day.

Vitiligo is an autoimmune disease in which there is a progressive depigmentation due to the loss of melanocytes in epidermis. In cell stress conditions, oxygen free radicals cause cell damage. In this inflammatory microenvironment, specific neoantigens are generated by melanocytes, like HSP70i, HMGB1 and S100B, leading to activation of innate and adaptive immune response. Eventually, dendritic cells present antigens to T lymphocytes, leading to destruction of melanocytes. Various studies have proven the central role that HSP70i plays in the pathogenesis of vitiligo, since its overexpression is associated with greater activation of dendritic cells, and therefore an increased lymphocytic infiltration in depigmented areas.

A relation between COVID‐19 and autoimmune phenomena has been reported. The most accepted theory considers that molecular mimicry between antigenic epitopes of the virus and certain human proteins, such as heat shock proteins (HSP60 y 90),could be the origin. In fact, these proteins have been associated with several autoimmune diseases triggered by COVID‐19 infection, like Guillain‐Barré syndrome, autoimmune bullous diseasesand some forms of vasculitis. Additionally, cross‐reactivity between SARS‐CoV‐2 and other tissular human proteins has been demonstrated, especially transglutaminase 2 and 3, ENA, myelin basic protein and even S100B.These findings suggest that a similar mechanism could be the cause of autoimmune diseases triggered by covid‐19 vaccination. However, IgG antibodies generated against SARS‐CoV‐2 have not been shown to be able to recognize and react against heat shock proteins.

Another possible mechanism suggested by Abdullah et al.posits that COVID‐19 infection would stimulate dendritic cells to produce massive amounts of IFN‐I, which also plays an important role in the pathogenesis of vitiligo. In the case of psoriatic flare‐up reactions, it has been suggested that the mRNA vaccines may cause a significant increase in IL‐6 production and recruitment of Th17 cells,which not only participate in the pathogenesis of psoriasis, but also in many other autoimmune diseases.

In conclusion, we report another case of vitiligo after COVID‐19 vaccine in a patient with unremarkable medical history. Although mechanism remains unclear, given the suggestive time sequence following vaccination and the increasing number of cases reported, we believe these hypothesis deserve further investigation




Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.